News
7h
Everyday Health on MSNZebound Beats Wegovy for Weight Loss in First Head-to-Head TrialIn a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
A new study led by York University, looking at the health data of nearly 15,000 people enrolled in a medically supervised ...
Weight-loss jabs have been hailed as the key to longer life even if you are not overweight, according to experts.
Weight-loss drugs like Ozempic and Wegovy could usher in a “golden age” of medicine due to their ability to delay diseases associated with ageing.
Studies have shown that GLP-1s reduce inflammation in the brain and regulate anxiety as well as depression. When insurance ...
DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market ...
Most Britons could soon use weight loss jabs to live longer, Britain’s most eminent medic has said. Experts hailed a “golden age” in obesity treatment thanks to drugs which have been found to halve ...
The NHS has been urged to accelerate the rollout of weight loss drugs to “many millions” of people, as experts hailed the start of a “golden age” of anti-obesity treatments. A raft of studies ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...
If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...
The best metric is not weight, but a particularly toxic kind of fat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results